Soluble guanylyl cyclase (sGC) is one of the crucial enzymes in the NO-cyclic GMP (cGMP) signaling cascade involved in smooth muscle relaxation, inhibition of platelet aggregation, and neurotransmission. sGC is the target of various pharmacological compounds currently used for treatment of cardiovascular disorders. However, the mechanisms governing stimulation of activity or expression of sGC are poorly understood. Effective manipulation of sGC-dependent synthesis of cGMP for therapeutic purposes requires understanding of the pathways involved in regulation of sGC levels and activity. The goal of this proposal is to determine the molecular mechanism of enzyme activation by alisoteric effectors including development of approaches for NO-independent regulation of sGC, investigation of the mechanisms regulating sGC expression, and analysis of the effects of short-term and long-term modulation of sGC activity and expression on cell physiology. To achieve this goal, a constitutively activated sGC mutant will be expressed in a cell model providing for elevated levels of cGMP, whereas expression of domains involved in formation of functional heterodimers of sGC will result in decreased enzyme levels and lowered NO-dependent synthesis of cGMP. The promoter fragments of sGC genes will be identified and characterized as well as the mechanisms of post-transcriptional regulation of sGC Human cell culture models will be developed and the effects of short-term and long-term sGC regulation on cell physiology will be determined. The knowledge of the mechanism of sGC regulation will advance our understanding of the role of sGC/cGMP system in various biological processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM061731-03S1
Application #
6925318
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Somers, Scott D
Project Start
2002-08-01
Project End
2006-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
3
Fiscal Year
2004
Total Cost
$103,950
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Biology
Type
Schools of Medicine
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225
Kots, Alexander Y; Choi, Byung-Kwon; Estrella-Jimenez, Maria E et al. (2008) Pyridopyrimidine derivatives as inhibitors of cyclic nucleotide synthesis: Application for treatment of diarrhea. Proc Natl Acad Sci U S A 105:8440-5
Bian, Ka; Doursout, Marie-Francoise; Murad, Ferid (2008) Vascular system: role of nitric oxide in cardiovascular diseases. J Clin Hypertens (Greenwich) 10:304-10
Sharina, Iraida G; Jelen, Filip; Bogatenkova, Elena P et al. (2008) Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity. J Biol Chem 283:15104-13
Zhu, Haifeng; Wei, Xiaofei; Bian, Ka et al. (2008) Effects of nitric oxide on skin burn wound healing. J Burn Care Res 29:804-14
Seminara, Aurora R; Ruvolo, Peter P; Murad, Ferid (2007) LPS/IFNgamma-induced RAW 264.7 apoptosis is regulated by both nitric oxide-dependent and -independent pathways involving JNK and the Bcl-2 family. Cell Cycle 6:1772-8
Zhu, Haifeng; Ka, Bian; Murad, Ferid (2007) Nitric oxide accelerates the recovery from burn wounds. World J Surg 31:624-31
Mujoo, Kalpana; Krumenacker, Joshua S; Wada, Yoshiko et al. (2006) Differential expression of nitric oxide signaling components in undifferentiated and differentiated human embryonic stem cells. Stem Cells Dev 15:779-87
Krumenacker, Joshua S; Katsuki, Shoji; Kots, Alexander et al. (2006) Differential expression of genes involved in cGMP-dependent nitric oxide signaling in murine embryonic stem (ES) cells and ES cell-derived cardiomyocytes. Nitric Oxide 14:1-11
Martin, Emil; Berka, Vladimir; Bogatenkova, Elena et al. (2006) Ligand selectivity of soluble guanylyl cyclase: effect of the hydrogen-bonding tyrosine in the distal heme pocket on binding of oxygen, nitric oxide, and carbon monoxide. J Biol Chem 281:27836-45
Krumenacker, Joshua S; Murad, Ferid (2006) NO-cGMP signaling in development and stem cells. Mol Genet Metab 87:311-4

Showing the most recent 10 out of 20 publications